Search

Author/Creator Gaughan, Elizabeth M

1. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). Issue 9 (13th September 2022)

Authors:
Vavolizza, Rick Daniel; Petroni, Gina R; Mauldin, Ileana S; Chianese-Bullock, Kimberly A; Olson, Walter C; Smith, Kelly T; Dengel, Lynn T; Haden, Kathleen; Grosh, William W; Kaur, Varinder; Varhegyi, Nikole; Gaughan, Elizabeth M; Slingluff, Craig L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63). Issue 1 (21st January 2021)

Authors:
Slingluff, Jr., Craig L; Petroni, Gina R; Chianese-Bullock, Kimberly A; Wages, Nolan A; Olson, Walter C; Smith, Kelly T; Haden, Kathleen; Dengel, Lynn T; Dickinson, Anna; Reed, Caroline; Gaughan, Elizabeth M; Grosh, William W; Kaur, Varinder; Varhegyi, Nikole; Smolkin, Mark; Galeassi, Nadejda V; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗